UK Covid-19 trial finds no benefit of gout drug in hospitalised adults

An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said.

A large British trial has halted enrolments to test gout drug colchicine as a potential treatment for patients hospitalised with Covid-19, after a sub-study of the trial found that the medication did not have any effect on the patients.

The study is the world's largest trial of treatments for hospitalised Covid-19 adults. (Reuters file photo. Representative image)

An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said. The study is the world's largest trial of treatments for hospitalised Covid-19 adults.